On the upside
Shares of LogMeIn (Nasdaq: LOGM) surged on its first day of trading.
MoneyGram International (NYSE: MGI) will provide money transfer services at Saudi Arabia's National Commercial Bank.
American International Group (NYSE: AIG) executed a 1-for-20 reverse stock split.
On the downside
Repros Therapeutics (Nasdaq: RPRX) halted the use of a higher 50 mg dose of its endometriosis treatment Proellex after an increase in liver enzymes in a few patients.
Acorda Therapeutics (Nasdaq: ACOR) sold the overseas rights to its multiple sclerosis treatment Fampridine-SR to Biogen Idec (Nasdaq: BIIB).
Immersion (Nasdaq: IMMR) initiated an internal review of certain revenue transactions.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by more than 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks gained 9 points to 517.
